Arthritis Drugs Archive | 2006

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 28

Merck-Sponsored Report Finds Managers Didn't Conceal Vioxx Concerns

Read Full Article

Journal Watch, Arthritis Drugs, September 2006

Read Full Article

Federal Judge Vacates $51 Million Vioxx Award, Orders New Trial

Read Full Article

Merck Reports Mixed Study Results of COX-2 Arcoxia Risks

Read Full Article

FDA Expands Remicade Approval for Psoriatic Arthritis Treatment

Read Full Article

Judge Says FDA Authority Preempts Celebrex Failure-to-Warn Claims

Read Full Article



Arthritis Drugs - Issue: 27

Arthritis Drugs in the Medical Literature This Month - August 2006

Read Full Article



Arthritis Drugs - Issue: 28

Jury Finds Merck Failed to Warn of Vioxx Risks, Awards Plaintiff $51 Million

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.